Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 2,085.00
-35.00 (-1.65%)
Oct 26, 2026, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 61.51 billion as of October 26, 2026. It is the 30,686th most valuable company in the world and the 1,640th biggest in South Korea. Its market cap has decreased by 41.60% in one year.
Market Cap
61.51B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,640 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 61.51B, a decrease of -87.25%. That is a compound annual growth rate of -23.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 61.51B | -27.10% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam Chun Dang Pharm. | 4.66T |
| PharmaResearch | 2.49T |
| ST Pharm | 1.88T |
| Mezzion Pharma | 1.76T |
| Oscotec | 1.43T |
| DongKook Pharmaceutical | 1.10T |
| Huons Global | 271.01B |
| KOLMAR BNH | 213.91B |